gold has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afif, N; Chatelus, E; Goetz, J; Lipsker, D; Sibilia, J; Sordet, C; Sparsa, L | 1 |
| Bieber, T; Tüting, T; Uerlich, M; Wenzel, J | 1 |
| Balsa, A; Bernad, M; Crespo, M; de Miguel, E | 1 |
1 review(s) available for gold and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
[Systemic treatment of cutaneous lupus erythematosus].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antimalarials; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Dapsone; Dermatologic Agents; Female; Gold; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Lupus Erythematosus, Cutaneous; Male; Methotrexate; Plasmapheresis; Pregnancy; Retinoids; Thalidomide; Time Factors | 2003 |
2 other study(ies) available for gold and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Jessner-Kanof disease induced by leflunomide: a dermal variant of cutaneous lupus?
Topics: Antibodies, Antinuclear; Antirheumatic Agents; Chloroquine; Female; Gold; Humans; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Middle Aged; Treatment Outcome | 2011 |
[Subacute cutaneous lupus erythematosus caused by chrysotherapy in rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Female; Gold; Humans; Lupus Erythematosus, Cutaneous; Middle Aged; Sjogren's Syndrome | 1988 |